CRBG
Corebridge Financial, Inc.
CRBG has a slight edge over GS overall, supported by stronger modeled upside and stronger valuation.
GS
The Goldman Sachs Group, Inc.
GS's outlook is improving, though it still trails on the overall score.
CRBG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
CRBG's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like CRBG.
GS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
GS's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like GS.
CRBG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 6.7x | $35.97 | — |
| Cheap | 7.4x | $33.58 | -6.6% |
| Current | 8x | $35.97 | — |
| Fair | 9.6x | $43.16 | +20% |
| Expensive | 29x | $130 | +262% |
Historical ranges are pointers, not guarantees.
CRBG has the edge over GS in the historical PE scenario, which offers more potential upside but is not a forecast.
GS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.6x | $528 | -42% |
| Current | 13x | $914 | — |
| Forward | 13x | $914 | — |
| Fair | 14x | $940 | +2.9% |
| Expensive | 17x | $1,214 | +33% |
Historical ranges are pointers, not guarantees.
GS's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
CRBG Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CRBG's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
GS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for GS, with profitability improving. However, they disagree widely on these estimates.
CRBG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.39 | +19% |
| Q3 2026 | $4.51 | +178% |
| Q2 2026 | $1.56 | +$2.23 |
| Q1 2026 | $0.40 | -64% |
| Q4 2025 | -$0.68 | -118% |
| Q3 2025 | $1.62 | +$3.69 |
| Q2 2025 | -$0.67 | -121% |
| Q1 2025 | $1.12 | -71% |
| Q4 2024 | $3.72 | +118% |
CRBG earned $4.51 per share over the past year, up 178% from the year before.
GS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $72.35 | +4% |
| Q3 2026 | $69.58 | +41% |
| Q2 2026 | $64.82 | +43% |
| Q1 2026 | $54.75 | +27% |
| Q4 2025 | $51.32 | +27% |
| Q3 2025 | $49.22 | +44% |
| Q2 2025 | $45.37 | +45% |
| Q1 2025 | $43.08 | +68% |
| Q4 2024 | $40.54 | +77% |
GS has the edge over CRBG on earnings, with more consistent year-over-year improvement.
CRBG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6.2B | +14% |
| Q2 2026 | $3.9B | +43% |
| Q1 2026 | $4B | +10% |
| Q4 2025 | $6.8B | +2.2% |
| Q3 2025 | $5.4B | +107% |
| Q2 2025 | $2.7B | -26% |
| Q1 2025 | $3.6B | -38% |
| Q4 2024 | $6.6B | +97% |
CRBG's revenue has grown year over year for five quarters in a row: $6.2B last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 38% | +39 points |
| Q2 2026 | 1.3% | +24 points |
| Q1 2026 | 2.5% | +27 points |
| Q4 2025 | 14% | -30 points |
| Q3 2025 | -0.8% | +60 points |
| Q2 2025 | -22% | -35 points |
| Q1 2025 | -24% | -41 points |
| Q4 2024 | 44% | +97 points |
CRBG has the edge over GS on profitability, with a higher operating margin.
GS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +23% |
| Q2 2026 | $20.3B | +39% |
| Q1 2026 | $17.2B | +14% |
| Q4 2025 | $13.5B | -3% |
| Q3 2025 | $15.2B | +20% |
| Q2 2025 | $14.6B | +15% |
| Q1 2025 | $15.1B | +6% |
| Q4 2024 | $13.9B | +23% |
GS has the edge over CRBG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +2 points |
| Q2 2026 | 42% | +8.1 points |
| Q1 2026 | 38% | +0.2 points |
| Q4 2025 | 44% | +5.6 points |
| Q3 2025 | 36% | +4.1 points |
| Q2 2025 | 34% | +3.2 points |
| Q1 2025 | 37% | +0.6 points |
| Q4 2024 | 38% | +18 points |
GS's operating margin was 37% last quarter, up 2 points from the same quarter a year ago.
CRBG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $605M | +2421% |
| Q2 2026 | -$44M | +$215M |
| Q1 2026 | -$9M | -102% |
| Q4 2025 | $1.9B | +27% |
| Q3 2025 | $24M | -71% |
| Q2 2025 | -$259M | -$250M |
| Q1 2025 | $375M | -37% |
| Q4 2024 | $1.5B | +93% |
CRBG has the edge over GS on cash generation, producing positive trailing cash flow while its opponent burns cash.
GS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +72% |
| Q2 2026 | $5.6B | +7.8% |
| Q1 2026 | -$32.4B | +$5.3B |
| Q4 2025 | -$16.8B | -136% |
| Q3 2025 | $2.1B | +$40.6B |
| Q2 2025 | $5.2B | -6.8% |
| Q1 2025 | -$37.7B | -$9.2B |
| Q4 2024 | $46.2B | +$75.1B |
GS's free cash flow was −$40B over the past year, against $15.8B the year before. Free cash flow isn't a meaningful measure for financial services companies like GS.
CRBG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -7M shares |
| 1 year | -17% | -93.4M shares |
| 3 years | -30% | -194M shares |
CRBG has the edge over GS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $185M |
| Q2 2026 | $300M |
| Q1 2026 | $1.3B |
| Q4 2025 | $1.1B |
| Q3 2025 | $380M |
| Q2 2025 | $311M |
| Q1 2025 | $321M |
| Q4 2024 | $398M |
CRBG spent $2.8B buying back its own shares over the past year, up 101% from the year before.
GS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -3.8M shares |
| 1 year | -4.4% | -13.9M shares |
| 3 years | -12% | -42.8M shares |
| 5 years | -15% | -52.8M shares |
| Available history | -20% | -74.4M shares |
GS has 301M diluted shares, down 4.4% from a year ago, with $15B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3B |
| Q2 2026 | $4B |
| Q1 2026 | $5B |
| Q4 2025 | $3B |
| Q3 2025 | $2B |
| Q2 2025 | $3B |
| Q1 2025 | $4.4B |
| Q4 2024 | $2B |
GS spent $15B buying back its own shares over the past year, up 32% from the year before.
CRBG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | 360.7x | High |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -1.3x | Net Cash |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 1.9x | Healthy |
CRBG's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago. Net leverage isn't a meaningful measure for financial services companies like CRBG.
GS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.4x | Net Cash |
| Q2 2026 | -6.1x | Net Cash |
| Q1 2026 | -6.7x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -3.1x | Net Cash |
| Q1 2025 | -3.9x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
GS has the edge over CRBG on leverage, with a lower net debt burden relative to earnings.
CRBG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.8 | Neutral |
| Stochastic | 72.5 | Neutral |
CRBG's weekly RSI is 66 (neutral) and its Stochastic is 73 (neutral).
GS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 16.3 | Oversold |
GS's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).
CRBG PE vs Financial Services Sector
| Metric | CRBG | Sector median | Relative |
|---|---|---|---|
| PE | 8x | 13x | 39% below |
| PE % | 29 | 57 | 28 pts below |
CRBG has the edge over GS on valuation relative to its sector.
GS PE vs Financial Services Sector
| Metric | GS | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.8% above |
| PE % | 46 | 63 | 17 pts below |
GS is trading at 13x earnings, in line with the Financial Services sector's median of 13x, though its earnings don't support one.
CRBG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.6 | 4.1% above |
| 20 week MA | $33.4 | 7.7% above |
| 50 week MA | $30.2 | 19% above |
| 100 week MA | $31.1 | 16% above |
| 200 week MA | $27.3 | 32% above |
CRBG has the edge over GS on trend strength, trading above more of its moving averages.
GS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $895.5 | 2% above |
| 20 week MA | $977.4 | 6.5% below |
| 50 week MA | $945.4 | 3.4% below |
| 100 week MA | $804.5 | 14% above |
| 200 week MA | $602.7 | 52% above |
GS's trend is mixed: it's above three of its five weekly moving averages, and 52% above its 200-week average.
CRBG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $20.7 | $20.3 | -2.2% |
| 2023 | $20.3 | $21.7 | +6.9% |
| 2024 | $21.7 | $30.0 | +39% |
| 2025 | $30.0 | $30.6 | +1.9% |
| 2026 YTD | $30.6 | $36.0 | +18% |
CRBG has the edge over GS on returns for 2026, with the stronger performance.
GS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $230.7 | $256.2 | +11% |
| 2021 | $256.2 | $385.0 | +50% |
| 2022 | $385.0 | $345.5 | -10% |
| 2023 | $345.5 | $385.8 | +12% |
| 2024 | $385.8 | $576.2 | +49% |
| 2025 | $576.2 | $907.0 | +57% |
| 2026 YTD | $907.0 | $913.6 | +0.7% |
GS has finished higher in five of the last six years, two of them by more than 50%. It's up 0.7% so far in 2026.